Sos, M. L., Koker, M., Weir, B. A., Heynck, S., Rabinovsky, R., Zander, T., . . . Thomas, R. K. (2009). PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.
Citação norma ChicagoSos, Martin L., et al. PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer By Activation of Akt and EGFR. 2009.
MLA CitationSos, Martin L., et al. PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer By Activation of Akt and EGFR. 2009.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.